Addenda Capital Inc.’s Thermo Fisher Scientific Inc Position
Does Addenda Capital Inc. own Thermo Fisher Scientific Inc (TMO)? Yes — 39.0K shares worth $20M (+0.53% of its 13F portfolio) as of Q2 2026, down from 39.5K shares the prior filed quarter.
Position Value
$20M
Q2 2026
Shares
39.0K
% of Portfolio
+0.53%
Quarters Held
31
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 39.0K | $20M | +0.53% |
| Q1 2026 | 39.5K | $19M | +0.55% |
| Q4 2025 | 29.5K | $17M | +0.50% |
| Q3 2025 | 29.8K | $14M | +0.43% |
| Q2 2025 | 21.1K | $9M | +0.31% |
| Q1 2025 | 19.2K | $10M | +0.35% |
| Q4 2024 | 19.3K | $10M | +0.35% |
| Q3 2024 | 18.0K | $11M | +0.40% |
| Q2 2024 | 18.0K | $10M | +0.39% |
| Q1 2024 | 19.4K | $11M | +0.43% |
| Q4 2023 | 23.5K | $12M | +0.49% |
| Q3 2023 | 23.6K | $12M | +0.52% |
| Q2 2023 | 23.9K | $12M | +0.52% |
| Q1 2023 | 29.5K | $17M | +0.70% |
| Q4 2022 | 29.9K | $16M | +0.72% |
| Q3 2022 | 32.1K | $16M | +0.74% |
| Q2 2022 | 38.1K | $21M | +0.99% |
| Q1 2022 | 43.9K | $26M | +1.06% |
| Q4 2021 | 41.0K | $27M | +1.18% |
| Q3 2021 | 43.1K | $25M | +1.16% |
| Q2 2021 | 47.2K | $24M | +1.12% |
| Q1 2021 | 47.5K | $22M | +1.13% |
| Q4 2020 | 47.5K | $22M | +1.39% |
| Q3 2020 | 51.8K | $23M | +1.67% |
| Q2 2020 | 54.9K | $20M | +1.39% |
| Q1 2020 | 57.6K | $16M | +1.39% |
| Q4 2019 | 50.4K | $16M | +1.08% |
| Q3 2019 | 47.5K | $14M | +0.97% |
| Q2 2019 | 48.8K | $14M | +1.04% |
| Q1 2019 | 57.2K | $16M | +1.13% |
| Q4 2018 | 54.1K | $12M | +1.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Addenda Capital Inc.’s full portfolio or all institutional holders of TMO.